Jeffrey T Yap

Jeffrey T Yap

UNVERIFIED PROFILE

Are you Jeffrey T Yap?   Register this Author

Register author
Jeffrey T Yap

Jeffrey T Yap

Publications by authors named "Jeffrey T Yap"

Are you Jeffrey T Yap?   Register this Author

29Publications

855Reads

28Profile Views

Lipopolysaccharide endotoxemia induces amyloid-β and p-tau formation in the rat brain.

Am J Nucl Med Mol Imaging 2018 25;8(2):86-99. Epub 2018 Apr 25.

Department of Radiology and Imaging Sciences, University of Utah Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944824PMC
April 2018

Method for detecting voxelwise changes in fluorodeoxyglucose-positron emission tomography brain images via background adjustment in cancer clinical trials.

J Med Imaging (Bellingham) 2017 Apr 1;4(2):024006. Epub 2017 Jun 1.

University of Utah, Huntsman Cancer Institute, Department of Radiology and Imaging Sciences, Salt Lake City, Utah, United States.

View Article

Download full-text PDF

Source
http://medicalimaging.spiedigitallibrary.org/article.aspx?do
Publisher Site
http://dx.doi.org/10.1117/1.JMI.4.2.024006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452430PMC
April 2017

Demonstration of DCE-MRI as an early pharmacodynamic biomarker of response to VEGF Trap in glioblastoma.

J Neurooncol 2016 12 30;130(3):495-503. Epub 2016 Aug 30.

Department of Radiology, Center for Quantitative Cancer Imaging, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, 84112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-016-2243-5DOI Listing
December 2016

FDG and FLT-PET for Early measurement of response to 37.5 mg daily sunitinib therapy in metastatic renal cell carcinoma.

Cancer Imaging 2015 Sep 3;15:15. Epub 2015 Sep 3.

Center for Quantitative Cancer Imaging, Huntsman Cancer Institute, University of Utah, 1950 Circle of Hope Dr, Suite 6810, Salt Lake City, UT, 84112-5560, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40644-015-0049-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558962PMC
September 2015

Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003).

J Clin Oncol 2015 Aug 13;33(24):2623-31. Epub 2015 Jul 13.

Nancy U. Lin, Hao Guo, Nicole Ryabin, Julie S. Najita, William T. Barry, Ian E. Krop, Eric P. Winer, and Annick D. Van den Abbeele, Dana-Farber Cancer Institute; Andrea L. Richardson and Annick D. Van den Abbeele, Brigham and Women's Hospital, Boston, MA; Jeffrey T. Yap, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Ingrid A. Mayer and Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center, Nashville, TN; Carla I. Falkson, University of Alabama, Birmingham, AL; Timothy J. Hobday, Mayo Clinic, Rochester, MN; E. Claire Dees, University of North Carolina, Chapel Hill, NC; Rita Nanda, University of Chicago, Chicago, IL; Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX; and Antonio C. Wolff, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.0353DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534525PMC
August 2015

A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancer.

Clin Genitourin Cancer 2015 Apr 22;13(2):113-23. Epub 2014 Oct 22.

Medical Oncology, Dana-Farber Cancer Institute and Internal Medicine, Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2014.08.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418946PMC
April 2015

Stand up to cancer phase Ib study of pan-phosphoinositide-3-kinase inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.

J Clin Oncol 2014 Apr 24;32(12):1202-9. Epub 2014 Mar 24.

Ingrid A. Mayer, Vandana G. Abramson, Justin M. Balko, María Gabriela Kuba, Melinda E. Sanders, and Carlos L. Arteaga, Vanderbilt University, Nashville, TN; Steven J. Isakoff, Massachusetts General Hospital, Boston, MA; Andres Forero, University of Alabama, Birmingham, AL; Jeffrey T. Yap, Huntsman Cancer Institute, Salt Lake City, UT; Annick D. Van den Abbeele and Eric Winer, Dana-Farber Cancer Institute, Boston, MA; Yisheng Li, MD Anderson Cancer Center, Houston, TX; and Lewis C. Cantley, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/03/18/JCO.2013.54
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.54.0518
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.54.0518DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986383PMC
April 2014

Voxelwise single-subject analysis of imaging metabolic response to therapy in neuro-oncology.

Stat 2014 Jan;3(1):172-186

Department of Statistics, North Carolina State University, 2311 Stinson Drive, Raleigh, NC 27615.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/sta4.53DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078880PMC
January 2014

Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin.

J Clin Oncol 2013 Sep 17;31(26):3182-90. Epub 2013 Jun 17.

F. Stephen Hodi, Anita Giobbie-Hurder, Philip Friedlander, Jason J. Luke, Katherine A. Zukotynski, Jeffrey T. Yap, Annick D. Van den Abbeele, and George D. Demetri, Dana-Farber Cancer Institute; Jonathan A. Fletcher, Meijun Zhu, and Adrian Marino-Enriquez, Brigham and Women's Hospital; Donald Lawrence, Keith T. Flaherty, and David E. Fisher, Massachusetts General Hospital, Boston, MA; Christopher L. Corless, Michael C. Heinrich, and Carol Beadling, Portland Veterans Administration Medical Center and Oregon Health & Science University, Portland, OR; Philip Friedlander, Mount Sinai Medical Center, New York, NY; Rene Gonzalez, University of Colorado Cancer Center, Aurora, CO; Jeffrey S. Weber, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Thomas F. Gajewski, University of Chicago, Chicago, IL; Steven J. O'Day, Beverly Hills Cancer Center, Beverly Hills, CA; Kevin B. Kim, The University of Texas MD Anderson Cancer Center, Houston, TX; Frances A. Collichio, The University of North Carolina at Chapel Hill, Chapel Hill, NC; and Marc S. Ernstoff, Geisel School of Medicine and Norris Cotton Cancer Center, Hanover, NH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.47.7836DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878082PMC
September 2013

Evaluating FDG uptake changes between pre and post therapy respiratory gated PET scans.

Radiother Oncol 2012 Mar 20;102(3):377-82. Epub 2012 Jan 20.

Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2011.12.015DOI Listing
March 2012

Clinical utility of 4D FDG-PET/CT scans in radiation treatment planning.

Int J Radiat Oncol Biol Phys 2012 Jan 4;82(1):e99-105. Epub 2011 Mar 4.

Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2010.12.060DOI Listing
January 2012

Four-dimensional positron emission tomography: implications for dose painting of high-uptake regions.

Int J Radiat Oncol Biol Phys 2011 Jul 13;80(3):900-8. Epub 2010 Oct 13.

Departments of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2010.08.028DOI Listing
July 2011

Evaluation of low-density neutral oral contrast material in PET/CT for tumor imaging: results of a randomized clinical trial.

AJR Am J Roentgenol 2009 Aug;193(2):326-32

Department of Radiology, Brigham and Women's Hospital, 1620 Tremont St., 3rd Fl., Radiology Ste., Boston, MA 02120, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.08.1565DOI Listing
August 2009

Image-guided cancer therapy using PET/CT.

Cancer J 2004 Jul-Aug;10(4):221-33

Department of Medicine, University of Tennessee Medical Center, Knoxville, Tennessee 37920-6999, USA.

View Article

Download full-text PDF

Source
January 2005

PET/CT today and tomorrow.

J Nucl Med 2004 Jan;45 Suppl 1:4S-14S

Department of Medicine, University of Tennessee Medical Center, Knoxville, Tennessee 37920-6999, USA.

View Article

Download full-text PDF

Source
January 2004

Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate.

J Clin Oncol 2003 Aug 13;21(15):2823-30. Epub 2003 Jun 13.

Cancer Research United Kingdom Positron Emission Tomography Oncology Group, Hammersmith Hospital, United Kingdom, UK.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2003.05.186
Publisher Site
http://dx.doi.org/10.1200/JCO.2003.05.186DOI Listing
August 2003